Statistics
Publications
5
Citations
360
H-Index
5
Active since
2019
Matthias Bormann is an author at Charité - Universitätsmedizin Berlin specializing in hodgkin lymphoma treatment, cancer immunotherapy, and oncology.
Publications per year
2019–2022
5
5
Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma
Paul J. Bröckelmann, Helen Goergen, Ulrich Keller et al. · JAMA Oncology · 2020 · 169 citations · Full text
Pharmacy, Oncology, Pharmacotherapy +16
Paul J. Bröckelmann, Ina Bühnen, Karolin Trautmann‐Grill et al. · Journal of Clinical Oncology · 2022 · 92 citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Andreas Burchert, Christian Michel, Stephan Metzelder et al. · Blood · 2022 · 13 citations
Nivolumab and AVD for Early-Stage Unfavorable Hodgkin Lymphoma (NIVAHL)
Paul J. Bröckelmann, Helen Goergen, Ulrich Keller et al. · Blood · 2019 · 12 citations
Medicine, Immunology, Oncology +9
1–5 of 5